Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim, +9

New England Journal of Medicine

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, +10

New England Journal of Medicine

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

Peter Angus, Rhys Vaughan, Shelly Xiong, +9

Gastroenterology

Novel MutationMolecular VirologyPathogenesisImmunologyDipivoxil Therapy +5

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, +11

New England Journal of Medicine

Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre- and Post-Liver Transplantation Patients

Eugene R. Schiff, Ching‐Lung Lai, Stefanos J. Hadziyannis, +19

Hepatology

Transplantation MedicineHepatitis BImmunologyPost-liver Transplantation PatientsPharmacotherapy +19

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

Jean‐Pierre Villeneuve, David Durantel, S. Durantel, +8

Journal of Hepatology

TransplantationHepatologyViral HepatitisHepatitis BHepatitis +7

The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro

William E. Delaney, Huiling Yang, Christopher Westland, +5

Journal of Virology

Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus

William E. Delaney, Adrian S. Ray, Huiling Yang, +4

Antimicrobial Agents and Chemotherapy

ImmunologyHepatitis BCell CultureHbv PolymeraseAntiviral Drug +18

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1 1Gilead Sciences gratefully acknowledges the patients, investigators, and study site personnel who participated in clinical trials GS-98-437 and GS-98-438.

C. Westland, William E. Delaney, Huiling Yang, +9

Gastroenterology

Site PersonnelHepatologyViral HepatitisHepatitis BHepatitis +6

<i>In Vitro</i> Susceptibility of Adefovir-Associated Hepatitis B Virus Polymerase Mutations to other Antiviral Agents

Xiaoping Qi, Shelly Xiong, Huiling Yang, +2

Antiviral Therapy